James Sherwood

1.3k total citations
18 papers, 949 citations indexed

About

James Sherwood is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James Sherwood has authored 18 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James Sherwood's work include Viral gastroenteritis research and epidemiology (13 papers), Respiratory viral infections research (8 papers) and Viral Infections and Immunology Research (7 papers). James Sherwood is often cited by papers focused on Viral gastroenteritis research and epidemiology (13 papers), Respiratory viral infections research (8 papers) and Viral Infections and Immunology Research (7 papers). James Sherwood collaborates with scholars based in United States, Switzerland and Japan. James Sherwood's co-authors include Gilbert M. Schiff, David I. Bernstein, Elizabeth C. Young, Robyn L. Ward, D R Knowlton, Peter D. Reuman, Monica McNeal, Paul M. Mendelman, Astrid Borkowski and Mary Clare Walker and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

James Sherwood

18 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Sherwood United States 15 685 285 264 193 178 18 949
Elizabeth C. Young United States 12 568 0.8× 235 0.8× 167 0.6× 135 0.7× 124 0.7× 12 788
S. Della Libera Italy 22 833 1.2× 245 0.9× 133 0.5× 148 0.8× 249 1.4× 36 1.2k
Alexis de Rougemont France 22 1.1k 1.7× 186 0.7× 379 1.4× 414 2.1× 194 1.1× 63 1.5k
Prasanna Samuel Premkumar India 12 895 1.3× 128 0.4× 290 1.1× 233 1.2× 163 0.9× 32 1.2k
D R Knowlton United States 20 1.2k 1.8× 167 0.6× 564 2.1× 467 2.4× 203 1.1× 29 1.4k
Walda B. van Zyl South Africa 15 521 0.8× 78 0.3× 193 0.7× 110 0.6× 117 0.7× 22 686
Richard Harry Asmah Ghana 19 512 0.7× 318 1.1× 263 1.0× 177 0.9× 206 1.2× 82 1.2k
H. Laveran France 17 594 0.9× 94 0.3× 176 0.7× 224 1.2× 110 0.6× 51 911
Anita Kambhampati United States 17 657 1.0× 292 1.0× 214 0.8× 179 0.9× 208 1.2× 37 968
Matías Victoria Uruguay 22 1.1k 1.6× 130 0.5× 296 1.1× 294 1.5× 154 0.9× 57 1.3k

Countries citing papers authored by James Sherwood

Since Specialization
Citations

This map shows the geographic impact of James Sherwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Sherwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Sherwood more than expected).

Fields of papers citing papers by James Sherwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Sherwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Sherwood. The network helps show where James Sherwood may publish in the future.

Co-authorship network of co-authors of James Sherwood

This figure shows the co-authorship network connecting the top 25 collaborators of James Sherwood. A scholar is included among the top collaborators of James Sherwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Sherwood. James Sherwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Atmar, Robert L., Khalil Ettayebi, Frederick H. Neill, et al.. (2024). Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels. The Journal of Infectious Diseases. 230(6). 1376–1379. 2 indexed citations
2.
López, Pío, Eduardo López-Medina, Xavier Sáez‐Llorens, et al.. (2023). Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial. Human Vaccines & Immunotherapeutics. 19(1). 2204787–2204787. 15 indexed citations
3.
Atmar, Robert L., Khalil Ettayebi, Sasirekha Ramani, et al.. (2023). A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. The Journal of Infectious Diseases. 229(5). 1402–1407. 10 indexed citations
4.
Vesikari, Timo, Xavier Sáez‐Llorens, Vesna Blazevic, et al.. (2022). Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study. Vaccine. 40(26). 3588–3596. 18 indexed citations
5.
Sherwood, James, Paul M. Mendelman, Eric Lloyd, et al.. (2020). Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults. Vaccine. 38(41). 6442–6449. 55 indexed citations
6.
Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2019). Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. The Journal of Infectious Diseases. 220(4). 603–614. 22 indexed citations
7.
Leroux‐Roels, Geert, Jakob P. Cramer, Paul M. Mendelman, et al.. (2017). Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial. The Journal of Infectious Diseases. 217(4). 597–607. 57 indexed citations
8.
Schiff, Gilbert M. & James Sherwood. (2000). Clinical Activity of Pleconaril in an Experimentally Induced Coxsackievirus A21 Respiratory Infection. The Journal of Infectious Diseases. 181(1). 20–26. 60 indexed citations
9.
Schiff, Gilbert M., James Sherwood, Jerome B. Zeldis, & David Krause. (1995). Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. Journal of Adolescent Health. 16(1). 12–17. 45 indexed citations
10.
Ward, Richard L., et al.. (1992). Salivary antibody titers in adults challenged with a human rotavirus. Journal of Medical Virology. 36(3). 222–225. 15 indexed citations
11.
Ward, Robyn L., David I. Bernstein, D R Knowlton, et al.. (1991). Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. Journal of Clinical Microbiology. 29(9). 1991–1996. 74 indexed citations
12.
Reuman, Peter D., David I. Bernstein, Scott P. Keely, et al.. (1990). Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Research. 13(3). 103–110. 16 indexed citations
13.
Ward, Robyn L., David I. Bernstein, Rakesh Shukla, et al.. (1990). Protection of Adults Rechallenged with a Human Rotavirus. The Journal of Infectious Diseases. 161(3). 440–445. 39 indexed citations
14.
Reuman, Peter D., David I. Bernstein, Michael C. Keefer, et al.. (1989). Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Research. 11(1). 27–40. 71 indexed citations
15.
Ward, Robyn L., David I. Bernstein, Elizabeth C. Young, et al.. (1989). Effects of Antibody to Rotavirus on Protection of Adults Challenged with a Human Rotavirus. The Journal of Infectious Diseases. 159(1). 79–88. 113 indexed citations
16.
Reuman, Peter D., David I. Bernstein, Scott P. Keely, et al.. (1989). Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A. Journal of Medical Virology. 27(2). 137–141. 11 indexed citations
17.
Bernstein, David I., Peter D. Reuman, James Sherwood, Elizabeth C. Young, & Gilbert M. Schiff. (1988). Ribavirin small-particle-aerosol treatment of influenza B virus infection. Antimicrobial Agents and Chemotherapy. 32(5). 761–764. 19 indexed citations
18.
Ward, Robyn L., David I. Bernstein, Elizabeth C. Young, et al.. (1986). Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. The Journal of Infectious Diseases. 154(5). 871–880. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth C. Young Breakdown of academic impact, for papers by S. Della Libera Breakdown of academic impact, for papers by Alexis de Rougemont Breakdown of academic impact, for papers by Prasanna Samuel Premkumar Breakdown of academic impact, for papers by D R Knowlton Breakdown of academic impact, for papers by Walda B. van Zyl Breakdown of academic impact, for papers by Richard Harry Asmah Breakdown of academic impact, for papers by H. Laveran Breakdown of academic impact, for papers by Anita Kambhampati Breakdown of academic impact, for papers by Matías Victoria
Rankless by CCL
2026